Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QCOM vs MRNA✓SelectedUSD · MRNAQCOM vs MRNA performance historyLatest closeAs of+1.38%11/19
Stock and ETF performance explorer

QCOM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+33.3%
MRNA return
+159.5%
Excess return
-126.2%
Maximum drawdown
-44.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.4%+1.3%+0.1%+1.3%
7D-8.5%-13.8%+5.3%-7.7%
30D-7.8%-17.7%+9.9%-6.8%
3M+0.6%+14.3%-13.7%-0.7%
6M-16.4%+336.0%-352.4%-31.0%
YTD-3.8%+575.9%-579.7%-28.9%
1Y-0.4%+724.4%-724.8%-29.9%
All+33.3%+159.5%-126.2%+17.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling